In this edition of the SpheraNOW podcast, James Tehrani, Spark’s editor in chief speaks with Dr. Adrian Mulholland, a chemistry professor at the University of Bristol’s Centre for Computational Chemistry in England, about the VR technology he and his team are developing to research anti-viral medications for COVID-19 and other diseases.

Our Website uses cookies, which are small files sent by a Web server to your computer and often maintained on your hard drive. These are not programs that can damage your machine; they simply enable us to recognize your browser when you revisit our site. No personal information is stored in a cookie nor can such information be used to identify you. You may disable cookies in your browser; for more details please refer to the help function of your browser. However, please note that some of our Website features or services may not function properly without cookies.
Accept